Header
Ihr Suchergebnis
Sie recherchieren derzeit unangemeldet.Melden Sie sich an (Login) um den vollen Funktionsumfang der Datenbank nutzen zu können.
Sie suchen in allen Bereichen nach dem Autor Ulanova I.
In der Rubrik Zeitschriften haben wir 3 Beiträge für Sie gefunden
-
MerkenThe Eurasian Economic Union
Rubrik: Recht
(Treffer aus pharmind, Nr. 10, Seite 958 (2024))
Sorg T | Ulanova I | Pyykkönen M
The Eurasian Economic Union / Part 2: The Quality Normative Document*Part 1.1 of this series see Pharm. Ind. 2023;85(7):680–685 and Part 1.2 see Pharm. Ind. 2023;85(8):768–776. · Sorg T, Ulanova I, Pyykkönen M · Boehringer Ingelheim Pharma und Boehringer Ingelheim LLC und Boehringer Ingelheim RCV
Country-specific Requirements Quality Normative Document Quality Control Testing EAEU Module 1 The Eurasian Economic Union (EAEU) is a regional economic union with the member states Russia, Belarus, Kazakhstan, Armenia, and Kyrgyzstan. The main goal of the EAEU is to strengthen and harmonize the economic cooperation among the me^mber states to create a single common market as well as increasing the living standards within the union. This also includes the requirement to harmonize the marketing authorizations of the medicinal products, within the EAEU members states. In order to receive an overview about the regulatory institutions involved in the EAEU and the ...
-
MerkenThe Eurasian Economic Union
Rubrik: Ausland
(Treffer aus pharmind, Nr. 08, Seite 768 (2023))
Sorg T | Ulanova I | Pyykkönen M
The Eurasian Economic Union / Part 1.2: Insights and Legal Framework for the Registration and Life Cycle of Medicinal Products*Part 1.1 of this article see Pharm. Ind. 2023;85(7):680–685. · Sorg T1, Ulanova I2, Pyykkönen M3 · 1Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß und Boehringer Ingelheim LLC, Moscow (Russia) und Boehringer Ingelheim RCV GmbH & Co KG, Vienna (Austria)
An important step to achieve the goal of forming a single market for medicinal products in the EAEU is the harmonization of the already existing national marketing authorization with the new EAEU requirements. Whereas until December 31 st , 2020, it was possible to register products via national procedures, only EAEU submissions were allowed from January 1 st , 2021. For all existing national marketing authorizations which are not yet in compliance with the newly established EAEU requirements, it is mandatory to bring them into compliance with EAEU requirements by December 31 st , 2025. On basis of the different ...
-
MerkenThe Eurasian Economic Union
Rubrik: Ausland
(Treffer aus pharmind, Nr. 07, Seite 680 (2023))
Sorg T | Ulanova I | Pyykkönen M
The Eurasian Economic Union / Part 1.1: Insights and Legal Framework for the Registration and Life Cycle of Medicinal Products · Sorg T1, Ulanova I2, Pyykkönen M3 · 1Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß und Boehringer Ingelheim LLC, Moscow (Russia) und Boehringer Ingelheim RCV GmbH & Co KG, Vienna (Austria)
The Eurasian Economic Union (EAEU) is an international organization for regional integration and consists of 5 member states, namely the Republic of Armenia, the Republic of Belarus, the Republic of Kazakhstan, the Kyrgyz Republic, and the Russian Federation. The total EAEU population counts around 184 mn. people which is around 2,4 % of the world population and has a gross domestic product per capita (GDP, PPP) of over 5 bn. intl. dollars. This is around 3.8 % of the world GDP PPP in 2021 (table 1)[1, 2]. The pharmaceutical market in the EAEU was one of the most dynamic and fastest-growing markets worldwide. While having a relatively ...
